These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18034994)

  • 41. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro.
    Pu WT; Ma Q; Izumo S
    Circ Res; 2003 Apr; 92(7):725-31. PubMed ID: 12663489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low UVA doses activate the transcription factor NFAT in human fibroblasts by a calcium-calcineurin pathway.
    Mazière C; Morlière P; Louandre C; Conte MA; Gomilla C; Santus R; Antonicelli F; Hornebeck W; Mazière JC
    Free Radic Biol Med; 2005 Dec; 39(12):1629-37. PubMed ID: 16298688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart.
    Nakayama H; Wilkin BJ; Bodi I; Molkentin JD
    FASEB J; 2006 Aug; 20(10):1660-70. PubMed ID: 16873889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calcineurin in human heart hypertrophy.
    Ritter O; Hack S; Schuh K; Röthlein N; Perrot A; Osterziel KJ; Schulte HD; Neyses L
    Circulation; 2002 May; 105(19):2265-9. PubMed ID: 12010908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cisapride protects against cardiac hypertrophy via inhibiting the up-regulation of calcineurin and NFATc-3.
    Zhou X; Zhang Q; Zhao T; Bai X; Yuan W; Wu Y; Liu D; Li S; Ju J; Chege Gitau S; Chu W; Xu C; Lu Y
    Eur J Pharmacol; 2014 Jul; 735():202-10. PubMed ID: 24769415
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Electrical field stimulation induces cardiac fibroblast proliferation through the calcineurin-NFAT pathway.
    Chen QQ; Zhang W; Chen XF; Bao YJ; Wang J; Zhu WZ
    Can J Physiol Pharmacol; 2012 Dec; 90(12):1611-22. PubMed ID: 23210440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.
    Braz JC; Bueno OF; Liang Q; Wilkins BJ; Dai YS; Parsons S; Braunwart J; Glascock BJ; Klevitsky R; Kimball TF; Hewett TE; Molkentin JD
    J Clin Invest; 2003 May; 111(10):1475-86. PubMed ID: 12750397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TAK1 Regulates Myocardial Response to Pathological Stress via NFAT, NFκB, and Bnip3 Pathways.
    Li L; Chen Y; Li J; Yin H; Guo X; Doan J; Molkentin JD; Liu Q
    Sci Rep; 2015 Nov; 5():16626. PubMed ID: 26564789
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of the calcineurin-nuclear factor of activated T-cell signal transduction pathway in atrial fibrillation.
    Lin CC; Lin JL; Lin CS; Tsai MC; Su MJ; Lai LP; Huang SK
    Chest; 2004 Dec; 126(6):1926-32. PubMed ID: 15596694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The calcineurin-nuclear factor of activated T cells signaling pathway mediates the effect of corticotropin releasing factor and urocortins on catecholamine synthesis.
    Dermitzaki E; Tsatsanis C; Gravanis A; Margioris AN
    J Cell Physiol; 2012 May; 227(5):1861-72. PubMed ID: 21702050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo.
    Antos CL; McKinsey TA; Frey N; Kutschke W; McAnally J; Shelton JM; Richardson JA; Hill JA; Olson EN
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):907-12. PubMed ID: 11782539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac calcineurin during transition from hypertrophy to heart failure in rats.
    Hayashida W; Kihara Y; Yasaka A; Sasayama S
    Biochem Biophys Res Commun; 2000 Jun; 273(1):347-51. PubMed ID: 10873609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
    Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
    Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Switching feedback mechanisms realize the dual role of MCIP in the regulation of calcineurin activity.
    Shin SY; Choo SM; Kim D; Baek SJ; Wolkenhauer O; Cho KH
    FEBS Lett; 2006 Oct; 580(25):5965-73. PubMed ID: 17046757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Calcineurin/NFAT signaling in lymphoid malignancies.
    Gachet S; Ghysdael J
    Gen Physiol Biophys; 2009; 28 Spec No Focus():F47-54. PubMed ID: 20093726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway.
    Meissner JD; Umeda PK; Chang KC; Gros G; Scheibe RJ
    J Cell Physiol; 2007 Apr; 211(1):138-48. PubMed ID: 17111365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of the calcineurin-NFAT signalling cascade in the treatment of heart failure.
    Panther F; Williams T; Ritter O
    Recent Pat Cardiovasc Drug Discov; 2009 Nov; 4(3):180-6. PubMed ID: 19925438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes.
    Tongers J; Fiedler B; König D; Kempf T; Klein G; Heineke J; Kraft T; Gambaryan S; Lohmann SM; Drexler H; Wollert KC
    Cardiovasc Res; 2004 Aug; 63(3):545-52. PubMed ID: 15276480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-328 as a regulator of cardiac hypertrophy.
    Li C; Li X; Gao X; Zhang R; Zhang Y; Liang H; Xu C; Du W; Zhang Y; Liu X; Ma N; Xu Z; Wang L; Chen X; Lu Y; Ju J; Yang B; Shan H
    Int J Cardiol; 2014 May; 173(2):268-76. PubMed ID: 24631114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.